CRIS

Business Context and Reporting Period

Company: Curis, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 6, 2007 (Earliest event reported)
Event: Entry into Material Definitive Agreements and Unregistered Sales of Equity Securities.
Context: The Company consummated a private placement of common stock and warrants to selected institutional and accredited investors to raise capital.

Key Financial Metrics

Capital Raised: Approximately $14.5 million in gross proceeds from the Private Placement consummated on August 8, 2007.
Securities Issued:

• Initial Shares: 12,220,916 shares of Common Stock.
• Subsequent Shares: 1,410,106 shares of Common Stock.
• Total Shares Issued: 13,631,022 shares.

Warrants Issued:

• Initial Warrants: To purchase 4,277,322 shares.
• Subsequent Warrants: To purchase 493,537 shares.
• Total Warrants: To purchase 4,770,859 shares.

Pricing Terms:

• Unit Price: $1.06375 per unit (1 share + warrant for 0.35 shares).
• Warrant Exercise Price: $1.02 per share.
• Warrant Term: 5 years from issuance.

Other Metrics: The filing does not provide revenue, profit, cash flow, margins, or debt figures for the reporting period.

Material Changes

This filing reports a significant capital event rather than operational performance changes. The primary material change is the increase in outstanding equity and the creation of warrant obligations. Prior to the placement, three investors (Stephens Investment Management, LLC; OrbiMed Advisors LLC; and Biotechnology Value Fund, L.P.) held approximately 8.4%, 5.2%, and 5.1% of the Company's outstanding Common Stock, respectively. The filing does not provide comparative financial data against prior periods.

Guidance, Outlook, and Risks

Management Commentary: The filing focuses on the terms of the transaction and does not include forward-looking guidance on revenue or earnings.
Registration Rights and Penalties:

• The Company agreed to file a Registration Statement within 30 days of closing and use best efforts to have it declared effective within 120 days (or 150 days if reviewed).
• Liquidated Damages: If the Company fails to meet these deadlines ("Registration Default"), it must pay investors 1% of their purchase price per 30-day period of default, capped at 10% of the aggregate purchase price.

Warrant Restrictions:

• Beneficial Ownership Limit: Investors cannot exercise warrants if it would cause them to own more than 9.99% of outstanding shares, unless they provide 61 days' written notice to waive this restriction.
• Mandatory Exercise: The Company may force mandatory exercise of all warrants if the stock price exceeds $2.50 for 30 consecutive days.

Risks: Dilution to existing shareholders and potential cash outflows for liquidated damages if registration deadlines are missed.

Investor Verification Checklist

• Verify the final closing date and total gross proceeds received (stated as August 8, 2007, and ~$14.5 million).
• Confirm the filing status of the Registration Statement required within 30 days of closing to assess potential liquidated damages exposure.
• Review the updated capitalization table to understand the dilution impact of the 13.6 million new shares and 4.77 million warrant shares.
• Check for any waivers of the 9.99% beneficial ownership limitation by major investors.
• Monitor the stock price relative to the $2.50 threshold to assess the risk of mandatory warrant exercise.